Phreesia 

$19.99
16
-$0.41-2.01% 今天

统计数据

当日最高
20.5
当日最低
19.93
52周最高
29.16
52周最低
12.05
成交量
148,584
平均成交量
352,381
市值
1.48B
市盈率
-
股息收益率
-
股息
-

即将到来

收益

4Dec预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
-0.7
-0.56
-0.42
-0.28
预期每股收益
-0.278777
实际每股收益
N/A

人们还关注

此列表基于关注PHR的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

29.4$平均价格目标
最高估值为 $34。
来自过去6个月内的 10 个评级。这不是投资建议。
买入
80%
持有
20%
卖出
0%

关于

Technology Services
Packaged Software
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Show more...
首席执行官
Chaim Indig
员工
1438
国家
US
ISIN
US71944F1066

上市公司